Congenital toxoplasmosis
ICD-10 P37.1 is a billable code used to indicate a diagnosis of congenital toxoplasmosis.
Congenital toxoplasmosis is an infection caused by the parasite Toxoplasma gondii, which can be transmitted from an infected mother to her fetus during pregnancy. This condition is characterized by a range of clinical manifestations that may include chorioretinitis, hydrocephalus, intracranial calcifications, and other neurological deficits. The severity of symptoms can vary widely, with some infants presenting with severe manifestations at birth, while others may appear asymptomatic initially but develop complications later. Diagnosis is typically made through serological testing of the mother and/or the infant, and imaging studies may be utilized to assess for neurological involvement. Early detection and management are crucial to mitigate long-term developmental issues. Treatment often involves the use of pyrimethamine and sulfadiazine, along with folinic acid to prevent bone marrow suppression. Given the potential for significant morbidity associated with congenital toxoplasmosis, awareness and accurate coding are essential for appropriate clinical management and resource allocation.
Detailed documentation of clinical findings, diagnostic tests, and treatment plans is essential. Neonatologists should ensure that all manifestations of the condition are recorded.
Infants presenting with chorioretinitis or neurological symptoms in the NICU, requiring multidisciplinary management.
Consideration of the timing of maternal infection and its impact on infant outcomes is crucial for accurate coding.
Pediatricians should document developmental assessments and any late-onset complications that may arise.
Follow-up visits for infants diagnosed with congenital toxoplasmosis, monitoring for developmental milestones and potential complications.
Awareness of the long-term implications of congenital toxoplasmosis on child development is important for accurate coding and management.
Used to confirm maternal infection during pregnancy or assess infant status postnatally.
Document the indication for testing and results to support coding.
Neonatologists should ensure that testing is performed in a timely manner to facilitate early intervention.
Long-term effects can include vision problems, developmental delays, and neurological issues. Early diagnosis and treatment can help mitigate some of these complications.
